On April 30, 2019 Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and life-threatening conditions, reported that senior management will be participating at the SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on Tuesday, May 7, 2019 at the Lotte New York Palace Hotel in New York City (Press release, Tetraphase, APR 30, 2019, View Source [SID1234535623]). Guy Macdonald, President and Chief Executive Officer of Tetraphase, will also present a corporate overview at the UBS Global Healthcare Conference on Monday, May 20, 2019 at 1:30 p.m. ET at the Grant Hyatt Hotel in New York City.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the UBS Global Healthcare Conference presentation will be available on the Company’s website at View Source The archived presentation will be available for 30 days.